Latest news
AEP Looks 9.8% Overvalued on GF Value™ Amid Price-to-Sales Conce - GuruFocusGuruFocus · Sun, 09 Aug 2026 01:58:56 GMTAAOI Looks 514.0% Overvalued on GF Value™ - GuruFocusGuruFocus · Sat, 08 Aug 2026 05:39:57 GMTCPK Looks 2.7% Undervalued on GF Value™ as Price-to-Sales Signals Growth Expectations - GuruFocusGuruFocus · Fri, 07 Aug 2026 22:58:00 GMTVITL Looks 68.4% Undervalued on GF Value™ Amid Challenging Sales Environment - GuruFocusGuruFocus · Fri, 07 Aug 2026 13:56:43 GMTMP Looks 35.2% Overvalued on GF Value™ as Price-to-Sales Soars A - GuruFocusGuruFocus · Fri, 07 Aug 2026 11:58:00 GMTGTN Looks 15.1% Undervalued on GF Value™ - GuruFocusGuruFocus · Fri, 07 Aug 2026 10:51:17 GMTCTEV Looks 14.4% Undervalued on GF Value™ as Price-to-Sales Sign - GuruFocusGuruFocus · Fri, 07 Aug 2026 10:44:53 GMTLexicon Pharmaceuticals (LXRX) Stockholders Plan to Sell 1.26M S - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:31:47 GMT